Principle Investigator

 

  • GENESIS study, first in man evaluation of transcatheter aortic valve implantation with HYDRA valve.
  • MyVal-1: A prospective, multicentric, single arm, open label study of MyValTM Transcatheter Aortic Valve Replacement System in the treatment of severe symptomatic native aortic valve stenosis.

This is first in human safety and feasibility study.

  • A prospective, open label and multicentric clinical study to evaluate safety and performance of CREDENCETM BRS Sirolimus Eluting BioResorbable Peripheral Scaffold System in subjects with de novo native peripheral artery lesions.
  • A randomized, double-blind, placebo-controlled study to assess the effects of bempedoic acid (etc-1002) on the occurrence of major cardiovascular events in patients with, or at high risk for, cardiovascular disease who are statin intolerant.